Iran produces new generation of anti-omicron Barakat vaccine

Tehran (IP) - Iran's deputy health minister for research and technical affairs, announced the production of a new generation of Barakat vaccine with special efficacy against the Omicron variant.

Iran PressIran News: COV-Iran Barakat vaccine manufacturer previously announced the production of a special vaccine for Omicron and its success in animal testing.

Younes Panahi, Iran's deputy health minister for research and technical affairs, said that a new generation of Barakat vaccine will enter the clinical trial phase next week.

Preliminary results from studies of this updated vaccine indicate 100% neutralization of the Omicron strain with the new vaccine and its safety in animal studies.

The results of experiments with the anti- Omicron Barakat vaccine on animals showed that 100% of the animals receiving the vaccine had antibodies against the Omicron.

The current vaccines in the world do not prevent new strains such as Omicron, and if a vaccine is designed and produced for new strains such as Omicron, it will prevent new strains.

216

Read more:

2nd phase of COVIran Barekat vaccine production line to be launched

COV-Iran Barakat vaccine, game changer in immunizing Iranian society